-+ 0.00%
-+ 0.00%
-+ 0.00%

DiaMedica Therapeutics Q3 EPS $(0.21), Inline. Cash and Equivalents #34.9M

Benzinga·11/12/2026 21:33:30
Listen to the news
DiaMedica Therapeutics (NASDAQ:DMAC) reported quarterly losses of $(0.21) per share which met the analyst consensus estimate. This is a 23.53 percent decrease over losses of $(0.17) per share from the same period last year.